Clinical features and survival of treatment with Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease.

被引：0
|
作者：
Mendoza, M. A. P. [1 ]
Contreras, A. [1 ]
Lafuente, G. [1 ]
Luque Buzo, E. [1 ]
De la Casa Fages, B. [1 ]
Gonzalez, M. [1 ]
Perez Sanchez, J. [2 ]
Grandas Perez, F. [1 ]
机构：
[1] Dept Neurol, Madrid, Spain
[2] Movement Disorders Unit, Madrid, Spain
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-636
引用
收藏
页码：836 / 836
页数：1
相关论文
共 50 条
  • [1] Levodopa-carbidopa intestinal gel for advanced Parkinson's disease
    Bohlega S
    Abou Al-Shaar H
    Alkhairallah T
    中华物理医学与康复杂志, 2016, (03) : 179 - 179
  • [2] Problems related to levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease
    Udd, Marianne
    Lyytinen, Jukka
    Eerola-Rautio, Johanna
    Kenttamies, Anu
    Lindstrom, Outi
    Kylanpaa, Leena
    Pekkonen, Eero
    BRAIN AND BEHAVIOR, 2017, 7 (07):
  • [3] Effect of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients
    Takei, T.
    Uozumi, T.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 742 - 742
  • [4] The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England
    K. Ray Chaudhuri
    A. Simon Pickard
    Ali Alobaidi
    Yash J. Jalundhwala
    Prasanna L. Kandukuri
    Yanjun Bao
    Julia Sus
    Glynn Jones
    Christian Ridley
    Julia Oddsdottir
    Seyavash Najle-Rahim
    Matthew Madin-Warburton
    Weiwei Xu
    Anette Schrag
    PharmacoEconomics, 2022, 40 : 559 - 574
  • [5] The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson's Disease in England
    Chaudhuri, K. Ray
    Pickard, A. Simon
    Alobaidi, Ali
    Jalundhwala, Yash J.
    Kandukuri, Prasanna L.
    Bao, Yanjun
    Sus, Julia
    Jones, Glynn
    Ridley, Christian
    Oddsdottir, Julia
    Najle-Rahim, Seyavash
    Madin-Warburton, Matthew
    Xu, Weiwei
    Schrag, Anette
    PHARMACOECONOMICS, 2022, 40 (05) : 559 - 574
  • [6] Efficacy and safety of Levodopa-Carbidopa Intestinal Gel in the treatment of Parkinson's Disease
    Londero, E.
    dos Santos, A. P.
    Braga, R.
    de Barros, R.
    dos Reis, L.
    Freire, G.
    MOVEMENT DISORDERS, 2021, 36 : S220 - S220
  • [7] Efficacy of levodopa-carbidopa intestinal gel compared to oral levodopa-carbidopa in advanced Parkinson's disease: Sensitivity and responder analyses
    Boyd, J. T.
    Fernandez, H. H.
    Slevin, J. T.
    Espay, A. J.
    Standaert, D. G.
    Pritchett, Y.
    Zhang, W.
    Chatamra, K.
    Widnell, K. L.
    Benesh, J.
    MOVEMENT DISORDERS, 2013, 28 : S143 - S143
  • [8] Titration of Levodopa-Carbidopa Intestinal Gel in US Patients with Advanced Parkinson's Disease
    Aldred, Jason
    Davis, Thomas
    Zamudio, Jorge
    Kukreja, Pavnit
    Bergmann, Lars
    Li, Mei
    Standaert, David
    MOVEMENT DISORDERS, 2018, 33 : S93 - S93
  • [9] Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson's disease
    Valldeoriola, Francesc
    Jose Catalan, Maria
    Escamilla-Sevilla, Francisco
    Freire, Eric
    Olivares, Jesus
    Cubo, Esther
    Santos Garcia, Diego
    Calopa, Matilde
    Martinez-Martin, Pablo
    Carlos Parra, Juan
    Arroyo, Gloria
    Matias Arbelo, Jose
    NPJ PARKINSONS DISEASE, 2021, 7 (01)
  • [10] Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients
    Antonini, Angelo
    Fung, Victor S. C.
    Boyd, James T.
    Slevin, John T.
    Hall, Coleen
    Chatamra, Krai
    Eaton, Susan
    Benesh, Janet A.
    MOVEMENT DISORDERS, 2016, 31 (04) : 530 - 537
12345